Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
Liu KK, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons C, Maurer TS, Marala R, Brown J, Kong JX, Lee E, Werner W, Wenzel Z, Vage C.
Bioorg Med Chem Lett. 2009 Oct 30. [Epub ahead of print]PMID: 19914063 [PubMed - as supplied by publisher]Related articles